Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease-Reference-Cited by-同舟云学术

Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease

Published:2011-12-20 Issue:12 Volume:6 Page:e29074
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kodama Takashi,Togawa Tadayasu,Tsukimura Takahiro,Kawashima Ikuo,Matsuoka Kazuhiko,Kitakaze Keisuke,Tsuji Daisuke,Itoh Kohji,Ishida Yo-ichi,Suzuki Minoru,Suzuki Toshihiro,Sakuraba Hitoshi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference22 articles.

1. The GM2 gangliosidoses.;RA Graval,2001

2. Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.;M Jeyakumar;Blood,2001

3. Miglustat in late-onset Tay-Sahs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment.;BE Shapiro;Genet Med,2009

4. Effective gene therapy in an authentic model of Tay-Sachs-related diseases.;MB Cachón-González;Proc Natl Acad Sci USA,2006

5. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.;JP Lee;Nat Med,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multiplexed targeted method for profiling of serum gangliosides and glycosphingolipids: application to GM2-gangliosidosis;Analytical and Bioanalytical Chemistry;2024-08-27

2. Unraveling the diagnostic enigma: laboratory diagnosis of sphingolipid activator protein deficiencies;Journal of Laboratory and Precision Medicine;2024-07

3. Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses;Molecular Genetics and Metabolism;2024-07

4. Glycosphingolipids and central nervous system–related diseases;Glycosphingolipids in the Central Nervous System;2024

5. Functions of glycosphingolipids in the central nervous system;Glycosphingolipids in the Central Nervous System;2024